A randomised controlled trial to evaluate the effects of oral steroid therapy on the development of pulmonary fibrosis in patients with sarcoidosis

ISRCTN ISRCTN11814269
DOI https://doi.org/10.1186/ISRCTN11814269
Secondary identifying numbers G0000542
Submission date
11/12/2000
Registration date
11/12/2000
Last edited
25/04/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr A Newman-Taylor
Scientific

Department of Occupational and Environmental Medicine
Imperial College School of Medicine
National Heart & Lung Institute
1b Manresa Road
London
SW3 6LR
United Kingdom

Phone +44 (0)207-351 8328

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymSTARS (Steroid Therapy Assessment in Respiratory Sarcoidosis)
Study objectivesNot provided at time of registration
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedRespiratory disease
InterventionNot provided at time of registration.
Intervention typeOther
Primary outcome measureNot provided at time of registration.
Secondary outcome measuresNot provided at time of registration.
Overall study start date01/12/1999
Completion date01/12/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participantsNot provided at time of registration.
Key inclusion criteriaNot provided at time of registration.
Key exclusion criteriaNot provided at time of registration.
Date of first enrolment01/12/1999
Date of final enrolment01/12/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Department of Occupational and Environmental Medicine
London
SW3 6LR
United Kingdom

Sponsor information

Medical Research Council (MRC) (UK)
Research council

20 Park Crescent
London
W1B 1AL
United Kingdom

Phone +44 (0)20 7636 5422
Email clinical.trial@headoffice.mrc.ac.uk
Website http://www.mrc.ac.uk

Funders

Funder type

Government

Medical Research Council (UK)
Government organisation / National government
Alternative name(s)
Medical Research Council (United Kingdom), UK Medical Research Council, MRC
Location
United Kingdom

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan